First half of cold season ends with H1N1 hangover
All the hype around H1N1 that was so prevalent in 2009 is gone, leaving only the tough comparisons a year later. That makes the first half of the 2010-2011 cough-cold season an H1N1 hangover with overall sales of $4.6 billion, representing a slight decline of 1.8%, for the 52 weeks ended Dec. 26, 2010, according to SymphonyIRI Group. What was missing in 2010 was the 2009 summer of sickness that reached a crescendo in September.
For the coming year, the introduction of Allegra to over-the-counter aisles will bring a whole new once-prescription-only allergy consumer to OTC. And though Allegra is not expected to reach the sales heights of more than $200 million like its two second-generation antihistamine predecessors, an incremental $100 million to OTC allergy sales is not out of the question.
Second is the growing number of states considering a reverse-switch and pushing pseudoephedrine-containing products back to prescription-only status. If successful, that may create a snowball effect among neighboring state legislators and threaten the “D” business that generated $263.7 million in sales on growth of 1% across the top three brands — Claritin-D, Mucinex D and Zyrtec-D.
The article above is part of the DSN Category Review Series. For the complete Cough-Cold Buy-In Report, including extensive charts, data and more analysis, click here.
Perrigo gains entry to store-brand blood-glucose meter market
ALLEGAN, Mich. — Perrigo on Thursday announced that it has entered into an exclusive agreement with AgaMatrix to sell and distribute blood-glucose monitors and test strips in the U.S. store-brand channel.
Nipro Diagnostics long has dominated store-brand blood-glucose meters with a co-branding program that includes TRUE2Go, TRUEresult and TRUEtrack.
As part of the agreement, Perrigo will sell and distribute certain products in the current AgaMatrix portfolio, as well as certain future new products.
Terms of the deal were not disclosed.
"Entering this adjacent product category has been high on our strategic priority list due to the fact that the growing diabetic community has an increasing demand for more quality, affordable healthcare options,” stated Joseph Papa, Perrigo chairman and CEO. “It is well-known that regular blood-glucose testing is critical to effective diabetes management. What is also well-known is that the cost of testing strips and supplies often prevents many diabetics from testing as often as they should."
ViVa Beverages introduces new relaxation aids
SOUTHFIELD, Mich. — ViVa Beverages on Wednesday announced the national launches of Quick Beverages Sleep and Quick Beverages Relax, two new 2-oz. shots containing relaxation aids in a zero-calorie, sugar-free, berry-flavor drink.
"We live in a high-stress, amped-up, always-on-the-go society, which is why energy shots have grown into a huge category," stated Paul Fuegner of ViVa Beverages. "Quick Beverages Sleep and Relax are the all-natural alternatives to energy shots."
The two products are available at Vitamin World and on Amazon.com and currently are selling into drug stores and convenience stores. Suggested retail price is $2.99 per bottle.